封面
市场调查报告书
商品编码
1487680

口腔睡眠呼吸中止装置市场规模 - 按装置类型(下颚前移装置、舌头固定装置、快速上颚扩张)、按适应症、按购买类型、按性别、按最终用途、按配销通路和预测,2024 - 2032年

Oral Sleep Apnea Devices Market Size - By Device Type (Mandibular Advancement Devices, Tongue-retaining Devices, Rapid Maxillary Expansion), By Indication, By Purchase Type, By Gender, By End-use, By Distribution Channel & Forecast, 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 220 Pages | 商品交期: 2-3个工作天内

价格
简介目录

由于全球睡眠呼吸中止症盛行率不断上升,预计 2024 年至 2032 年间,口腔睡眠呼吸中止症设备市场规模将以 10.7% 的复合年增长率成长。根据美国国家健康研究所的数据,睡眠呼吸中止症影响着9.36 亿30 岁至69 岁的成年人。人员正在积极寻求替代解决方案。为此,口腔睡眠呼吸中止装置提供非侵入性且对患者友善的治疗选择,已获得了巨大的关注。

随着家庭和微创治疗的日益受到重视,口腔睡眠呼吸中止症装置为传统疗法(例如持续性呼吸道正压通气 (CPAP) 机)提供了一种方便且经济高效的替代方案。製造商和医疗保健提供者之间的合作,以及有利于口腔矫正器治疗的报销政策,以促进更大的市场渗透,将促进市场成长。

口腔睡眠呼吸中止症装置产业分为装置类型、适应症、购买类型、性别、最终用途、配销通路和地区。

根据设备类型,到2032 年,快速上颚扩张细分市场的市场价值预计将达到10.6% 的复合年增长率。在治疗阻塞性牙齿矫正方面的潜力而获得认可。透过加宽上颚并增加呼吸道尺寸,快速上颚扩张装置可以减轻睡眠期间的呼吸道阻塞,从而改善呼吸并减少呼吸中止发作。

在配销通路方面,口腔睡眠呼吸中止设备市场的医院药房部分从2024年到2032年将录得10.1%的增长率。主要中心。随着人们对 OSA 及其潜在健康后果的认识不断提高,医院药局正在积极寻求有效的治疗方案来满足患者的需求。此外,医院还与医疗设备製造商和供应商建立了关係,以方便取得产品。

亚太地区口腔睡眠呼吸中止装置产业在 2024 年至 2032 年间将以 11.9% 的复合年增长率增长,原因是睡眠呼吸中止症疾病的盛行率不断上升,以及人们对其健康影响的认识不断提高。快速扩张的医疗基础设施和不断增长的可支配收入水准正在促进更多人获得口腔睡眠呼吸中止症装置。旨在促进睡眠健康和改善医疗服务可近性的政府措施正在促进整个地区的产品需求。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 睡眠呼吸中止症及相关併发症的盛行率不断上升
      • 技术进步
      • 人们对睡眠呼吸中止症和其他睡眠障碍的认识不断提高
      • 对口腔睡眠呼吸中止装置的需求不断增长
    • 产业陷阱与挑战
      • 严格规定
      • 缺乏对睡眠呼吸中止症治疗的依从性
  • 成长潜力分析
  • 波特的分析
  • PESTEL分析
  • 未来市场趋势
  • 报销场景
  • 监管环境
  • 技术景观
  • 缺口分析

第 4 章:竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章:市场估计与预测:按设备类型,2018 年 - 2032 年

  • 主要趋势
  • 下颚前移装置
  • 舌头固定装置
  • 上颚快速扩张
  • 护齿套

第 6 章:市场估计与预测:按指标划分,2018 年 - 2032 年

  • 主要趋势
  • 轻度睡眠呼吸中止症
  • 中度睡眠呼吸暂停
  • 严重睡眠呼吸中止症

第 7 章:市场估计与预测:按购买类型,2018 年 - 2032 年

  • 主要趋势
  • 医生处方/客製化口腔装置
  • 非处方口腔器械

第 8 章:市场估计与预测:按性别划分,2018 年 - 2032 年

  • 主要趋势
  • 男性
  • 女性

第 9 章:市场估计与预测:按最终用途,2018 - 2032 年

  • 主要趋势
  • 家庭护理设置
  • 睡眠实验室和医院
  • 牙医诊所

第 10 章:市场估计与预测:按配销通路划分,2018 年 - 2032 年

  • 主要趋势
  • 砖块和灰浆
  • 电子商务
  • 医院药房

第 11 章:市场估计与预测:按地区划分,2018 年 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区

第 12 章:公司简介

  • Apnea Sciences
  • DynaFlex
  • Glidewell
  • MPowrx Health & Wellness
  • Myerson LLC
  • OravanOSA
  • Panthera Dental
  • ProSomnus Sleep Technologies
  • PureSleep
  • ResMed
  • SomnoMed
  • Vivos Therapeutics, Inc.
简介目录
Product Code: 8530

Oral sleep apnea devices market size is anticipated to grow at 10.7% CAGR between 2024 and 2032, driven by the rising prevalence of sleep apnea globally. As per Nation Institute of Health, sleep apnea impacts 936 million adults between the ages of 30 and 69. As awareness about the adverse health effects of untreated sleep apnea is increasing, individuals and healthcare professionals are actively seeking alternative solutions. To that end, oral sleep apnea devices, which offer non-invasive and patient-friendly treatment options, have gained significant traction.

With growing emphasis on home-based and minimally invasive treatments, oral sleep apnea devices provide a convenient and cost-effective alternative to traditional therapies, such as continuous positive airway pressure (CPAP) machines. Collaborations between manufacturers and healthcare providers, along with reimbursement policies favoring oral appliance therapy to facilitate greater market penetration will add to the market growth.

The oral sleep apnea devices industry is classified into device type, indication, purchase type, gender, end use, distribution channel and region.

Based on device type, the market value from the rapid maxillary expansion segment is anticipated to witness 10.6% CAGR through 2032. This orthodontic technique, primarily used to address issues related to malocclusion and narrow dental arches, has gained recognition for its potential in treating obstructive sleep apnea (OSA). By widening the upper jaw and increasing airway dimensions, rapid maxillary expansion devices can alleviate airway obstruction during sleep for improving breathing and reducing apnea episodes.

In terms of distribution channel, the hospital pharmacies segment in the oral sleep apnea devices market will record 10.1% growth rate from 2024 to 2032. Hospital pharmacies are the primary centers for diagnosing and treating sleep disorders, including obstructive sleep apnea (OSA). As awareness about OSA and its potential health consequences is increasing, hospital pharmacies are actively seeking effective treatment options to meet patient needs. Additionally, hospitals have established relationships with medical device manufacturers and suppliers for facilitating easier access to the product.

Asia Pacific oral sleep apnea devices industry will grow at 11.9% CAGR between 2024 and 2032, attributed to the increasing prevalence of sleep apnea disorders, coupled with rising awareness about its health implications. The rapidly expanding healthcare infrastructure and growing disposable income levels are facilitating greater access to oral sleep apnea devices. Favorable government initiatives aimed at promoting sleep health and improving access to healthcare services are contributing to the product demand across the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of sleep apnea and related co-morbidities
      • 3.2.1.2 Technological advancements
      • 3.2.1.3 Surging awareness regarding sleep apnea and other sleep disorders
      • 3.2.1.4 Rising demand for oral sleep apnea devices
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Stringent regulations
      • 3.2.2.2 Lack of adherence to sleep apnea treatment
  • 3.3 Growth potential analysis
  • 3.4 Porter's analysis
    • 3.4.1 Supplier power
    • 3.4.2 Buyer power
    • 3.4.3 Threat of new entrants
    • 3.4.4 Threat of substitutes
    • 3.4.5 Industry rivalry
  • 3.5 PESTEL analysis
  • 3.6 Future market trends
  • 3.7 Reimbursement scenario
  • 3.8 Regulatory landscape
  • 3.9 Technological landscape
  • 3.10 GAP analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Device Type, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Mandibular advancement devices
  • 5.3 Tongue-retaining devices
  • 5.4 Rapid maxillary expansion
  • 5.5 Mouth guards

Chapter 6 Market Estimates and Forecast, By Indication, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Mild sleep apnea
  • 6.3 Moderate sleep apnea
  • 6.4 Severe sleep apnea

Chapter 7 Market Estimates and Forecast, By Purchase Type, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Physician-prescribed/customized oral devices
  • 7.3 OTC oral devices

Chapter 8 Market Estimates and Forecast, By Gender, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Male
  • 8.3 Female

Chapter 9 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 Homecare settings
  • 9.3 Sleep laboratories & hospitals
  • 9.4 Dental clinics

Chapter 10 Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 ($ Mn)

  • 10.1 Key trends
  • 10.2 Brick and mortar
  • 10.3 E-commerce
  • 10.4 Hospital pharmacies

Chapter 11 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 11.1 Key trends
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 France
    • 11.3.4 Italy
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 South Korea
    • 11.4.6 Rest of Asia Pacific
  • 11.5 Latin America
    • 11.5.1 Brazil
    • 11.5.2 Mexico
    • 11.5.3 Argentina
    • 11.5.4 Rest of Latin America
  • 11.6 Middle East and Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 South Africa
    • 11.6.3 UAE
    • 11.6.4 Rest of Middle East and Africa

Chapter 12 Company Profiles

  • 12.1 Apnea Sciences
  • 12.2 DynaFlex
  • 12.3 Glidewell
  • 12.4 MPowrx Health & Wellness
  • 12.5 Myerson LLC
  • 12.6 OravanOSA
  • 12.7 Panthera Dental
  • 12.8 ProSomnus Sleep Technologies
  • 12.9 PureSleep
  • 12.10 ResMed
  • 12.11 SomnoMed
  • 12.12 Vivos Therapeutics, Inc.